Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 343

1.

Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.

Wang X, Liu Z, Wang K, Wang Z, Sun X, Zhong L, Deng G, Song G, Sun B, Peng Z, Liu W.

Front Genet. 2016 Aug 2;7:140. doi: 10.3389/fgene.2016.00140. eCollection 2016.

2.

Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study.

Tian J, Zhong R, Liu C, Tang Y, Gong J, Chang J, Lou J, Ke J, Li J, Zhang Y, Yang Y, Zhu Y, Gong Y, Xu Y, Liu P, Yu X, Xiao L, Du M, Yang L, Yuan J, Wang Y, Chen W, Wei S, Liang Y, Zhang X, He M, Wu T, Yao P, Miao X.

Sci Rep. 2016 Aug 3;6:31006. doi: 10.1038/srep31006.

3.

Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.

Ravi Kanth VV, Sasikala M, Sharma M, Rao PN, Reddy DN.

World J Hepatol. 2016 Jul 18;8(20):827-37. doi: 10.4254/wjh.v8.i20.827. Review.

4.

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH.

Wan X, Xu C, Yu C, Li Y.

Can J Gastroenterol Hepatol. 2016;2016:6489012. doi: 10.1155/2016/6489012. Epub 2016 May 4. Review.

5.

Recent advances in understanding ichthyosis pathogenesis.

Marukian NV, Choate KA.

F1000Res. 2016 Jun 24;5. pii: F1000 Faculty Rev-1497. doi: 10.12688/f1000research.8584.1. eCollection 2016. Review.

6.

TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.

Hsieh J, Koseki M, Molusky MM, Yakushiji E, Ichi I, Westerterp M, Iqbal J, Chan RB, Abramowicz S, Tascau L, Takiguchi S, Yamashita S, Welch CL, Di Paolo G, Hussain MM, Lefkowitch JH, Rader DJ, Tall AR.

Nature. 2016 Jul 6;535(7611):303-7. doi: 10.1038/nature18628.

PMID:
27383786
7.

Novel phenotypes of prediabetes?

Häring HU.

Diabetologia. 2016 Sep;59(9):1806-18. doi: 10.1007/s00125-016-4015-3. Epub 2016 Jun 25. Review.

8.

The Immune Landscape in Nonalcoholic Steatohepatitis.

Narayanan S, Surette FA, Hahn YS.

Immune Netw. 2016 Jun;16(3):147-58. doi: 10.4110/in.2016.16.3.147. Epub 2016 Jun 17. Review.

9.

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.

Temple JL, Cordero P, Li J, Nguyen V, Oben JA.

Int J Mol Sci. 2016 Jun 15;17(6). pii: E947. doi: 10.3390/ijms17060947. Review.

10.

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter.

Arslanow A, Teutsch M, Walle H, Grünhage F, Lammert F, Stokes CS.

Clin Transl Gastroenterol. 2016 Jun 16;7(6):e176. doi: 10.1038/ctg.2016.28.

12.

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background.

Yu J, Marsh S, Hu J, Feng W, Wu C.

Gastroenterol Res Pract. 2016;2016:2862173. doi: 10.1155/2016/2862173. Epub 2016 May 9. Review.

13.

The Natural Course of Non-Alcoholic Fatty Liver Disease.

Calzadilla Bertot L, Adams LA.

Int J Mol Sci. 2016 May 20;17(5). pii: E774. doi: 10.3390/ijms17050774. Review.

14.

Insulin resistance in development and progression of nonalcoholic fatty liver disease.

Alam S, Mustafa G, Alam M, Ahmad N.

World J Gastrointest Pathophysiol. 2016 May 15;7(2):211-7. doi: 10.4291/wjgp.v7.i2.211. Review.

16.

Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis.

Matz-Soja M, Rennert C, Schönefeld K, Aleithe S, Boettger J, Schmidt-Heck W, Weiss TS, Hovhannisyan A, Zellmer S, Klöting N, Schulz A, Kratzsch J, Guthke R, Gebhardt R.

Elife. 2016 May 17;5. pii: e13308. doi: 10.7554/eLife.13308.

17.

Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.

Fengler VH, Macheiner T, Kessler SM, Czepukojc B, Gemperlein K, Müller R, Kiemer AK, Magnes C, Haybaeck J, Lackner C, Sargsyan K.

PLoS One. 2016 May 11;11(5):e0155163. doi: 10.1371/journal.pone.0155163. eCollection 2016.

18.

Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Zelber-Sagi S, Godos J, Salomone F.

Therap Adv Gastroenterol. 2016 May;9(3):392-407. doi: 10.1177/1756283X16638830. Epub 2016 Mar 17. Review.

19.

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review.

Petäjä EM, Yki-Järvinen H.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E633. doi: 10.3390/ijms17050633. Review.

20.

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Aragonès G, Auguet T, Armengol S, Berlanga A, Guiu-Jurado E, Aguilar C, Martínez S, Sabench F, Porras JA, Ruiz MD, Hernández M, Sirvent JJ, Del Castillo D, Richart C.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E630. doi: 10.3390/ijms17050630.

Items per page

Supplemental Content

Write to the Help Desk